Page 96 - PROGRAMME2018
P. 96

MONDAY, 2 JULY 2018
SELECTED ORAL COMMUNICATIONS
15:15 - 16:30 Room 116
Session 21: Female fertility preservation: clinical and laboratory
Chairman: K.L. Tryde Macklon (Denmark) Chairman: M. Esbert Algam (Spain)
   15:15
15:30
15:45
16:00
16:15
O-081 Potential leukaemic contamination in cryopreserved ovarian tissue
D. Gook1, D. Westerman2, M. McBean2, V. Hughes1, K. Stern1
1The Women's Hospital, Reproductive Services /Melbourne IVF, Parkville- Victoria, Australia 2Peter MacCallum Cancer Centre, Department of Pathology, Parkville- Victoria, Australia
O-082 LH gonadoprotection against ovarian damage induced by alkylating drugs in adult mouse ovaries
L.M. Castillo1, A. Buigues1, L. Pellegrini2, V. Rossi3, F. Klinger3, A. Pellicer4, S. Herraiz2 1University of Valencia, Department of Pediatrics- Obstetrics and Gynecology, Valencia, Spain 2Fundación IVI, Research, Valencia, Spain
3University of Rome Tor Vergata, Dep. Biomedicine and Prevention, Rome, Italy
4IVI-RMA, IVI Rome, Rome, Italy
O-083 Towards an artificial ovary: Grafting preantral follicles on decellularized human ovarian tissue
S. Pors1, S.G. Kristensen2, K. Lundsgaard2, M. Ramløse2, C.Y. Andersen2 1Rigshospitalet, Laboratory of Reproductive Biology, KØBENHAVN Ø, Denmark 2Rigshospitalet, Laboratory of Reproductive Biology, Copenhagen, Denmark
O-084 Primordial follicle activation in vitro following PTEN inhibition is associated with increased DNA damage of bovine ovarian follicles
M. Maidarti1, M. McLaughlin2, Y.L. Clarkson2, E.E. Telfer2, R.A. Anderson1
1University of Edinburgh, Center for Reproductive Health, Edinburgh, United Kingdom
2University of Edinburgh, Institute of Cell Biology and Centre for Integrative Physiology, Edinburgh, United Kingdom
O-085 Can we perform flexible antagonist protocol for luteal phase ovarian stimulation for breast cancer patients seeking fertility preservation?
M. Victoria1, M. Comtet1, M. Presse1, C. Sonigo1, I. Cedrin-Durnerin1, M. Grynberg1
1Hospital Jean Verdier 93140 Bondy Avenue du 14 Juillet, Reproductive medecine and Fertility Preservation, Paris, France
               96








































































   94   95   96   97   98